BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 31712247)

  • 1. Planning for success: overcoming challenges to recruitment and conduct of an open-label emergency department-led paediatric trial.
    Roper L; Lyttle MD; Gamble C; Humphreys A; Messahel S; Lee ED; Noblet J; Hickey H; Rainford N; Iyer A; Appleton R; Woolfall K
    Emerg Med J; 2021 Mar; 38(3):191-197. PubMed ID: 33051276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the chances of having a second epileptic seizure?
    Saul H; Deeney B; Cassidy S; Neligan A
    BMJ; 2023 Oct; 383():2285. PubMed ID: 37832961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-epileptic drug (AED) loading in status epilepticus: an audit and introduction of levetiracetam loading protocol.
    Gew J
    Future Healthc J; 2023 Nov; 10(Suppl 3):129-130. PubMed ID: 38406728
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
    Kapur J; Elm J; Chamberlain JM; Barsan W; Cloyd J; Lowenstein D; Shinnar S; Conwit R; Meinzer C; Cock H; Fountain N; Connor JT; Silbergleit R;
    N Engl J Med; 2019 Nov; 381(22):2103-2113. PubMed ID: 31774955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam for convulsive status epilepticus in childhood: systematic review and meta-analysis.
    Abdelgadir I; Hamud A; Kadri A; Akram S; Pullattayil A; Akobeng AK; Powell C
    Arch Dis Child; 2020 Oct; ():. PubMed ID: 33060105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line medication dosing in pediatric refractory status epilepticus.
    Vasquez A; GaĆ­nza-Lein M; Abend NS; Amengual-Gual M; Anderson A; Arya R; Brenton JN; Carpenter JL; Chapman K; Clark J; Farias-Moeller R; Gaillard WD; Glauser T; Goldstein JL; Goodkin HP; Guerriero RM; Kapur K; Lai YC; McDonough TL; Mikati MA; Morgan LA; Novotny EJ; Ostendorf AP; Payne ET; Peariso K; Piantino J; Riviello JJ; Sannagowdara K; Tasker RC; Tchapyjnikov D; Topjian A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2020 Nov; 95(19):e2683-e2696. PubMed ID: 32913024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis.
    Yi ZM; Zhong XL; Wang ML; Zhang Y; Zhai SD
    Front Pharmacol; 2020; 11():751. PubMed ID: 32670054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
    Nakra NA; Blumberg DA; Herrera-Guerra A; Lakshminrusimha S
    Children (Basel); 2020 Jul; 7(7):. PubMed ID: 32630212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Chamberlain JM; Kapur J; Shinnar S; Elm J; Holsti M; Babcock L; Rogers A; Barsan W; Cloyd J; Lowenstein D; Bleck TP; Conwit R; Meinzer C; Cock H; Fountain NB; Underwood E; Connor JT; Silbergleit R; ;
    Lancet; 2020 Apr; 395(10231):1217-1224. PubMed ID: 32203691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lyttle MD; Rainford NEA; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee ED; Potter S; Tate P; Iyer A; Evans V; Appleton RE;
    Lancet; 2019 May; 393(10186):2125-2134. PubMed ID: 31005385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update in the initial management of paediatric status epilepticus.
    Lawton B; Davis T; Goldstein H; Tagg A
    Curr Opin Pediatr; 2018 Jun; 30(3):359-363. PubMed ID: 29474272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Status Epilepticus: Phenytoin Versus Levetiracetam.
    Dell'Aquila J; Soti V
    Cureus; 2021 Oct; 13(10):e18515. PubMed ID: 34659919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam is a useful alternative to phenytoin for epileptic seizures in children.
    Cook R; Davidson P; Martin R;
    BMJ; 2019 Nov; 367():l5464. PubMed ID: 31712247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.